Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR

Publication date: Available online 1 April 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiaojia Liu, Mingxiao Yin, Jingwen Dong, Genxiang Mao, Wenjian Min, Zean Kuang, Peng Yang, Lu Liu, Na Zhang, Hongbin Deng
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research